Inmune Bio (INMB) Shares Outstanding (Diluted Average) (2021 - 2025)
Historic Shares Outstanding (Diluted Average) for Inmune Bio (INMB) over the last 5 years, with Q3 2025 value amounting to $26.6 million.
- Inmune Bio's Shares Outstanding (Diluted Average) rose 3170.36% to $26.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.6 million, marking a year-over-year increase of 3170.36%. This contributed to the annual value of $19.9 million for FY2024, which is 1092.01% up from last year.
- As of Q3 2025, Inmune Bio's Shares Outstanding (Diluted Average) stood at $26.6 million, which was up 3170.36% from $23.3 million recorded in Q2 2025.
- In the past 5 years, Inmune Bio's Shares Outstanding (Diluted Average) ranged from a high of $26.6 million in Q3 2025 and a low of $16.1 million during Q4 2021
- Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $18.0 million (2023), whereas its average is $19.2 million.
- In the last 5 years, Inmune Bio's Shares Outstanding (Diluted Average) changed by 0.0% in 2023 and then surged by 3170.36% in 2025.
- Inmune Bio's Shares Outstanding (Diluted Average) (Quarter) stood at $16.1 million in 2021, then grew by 11.14% to $17.9 million in 2022, then rose by 0.3% to $18.0 million in 2023, then increased by 10.92% to $19.9 million in 2024, then surged by 33.3% to $26.6 million in 2025.
- Its Shares Outstanding (Diluted Average) stands at $26.6 million for Q3 2025, versus $23.3 million for Q2 2025 and $22.5 million for Q1 2025.